Marc van der Waude, Marc van der Waude, Nov 01, 2009
The purpose of this contribution is to explore the status types that settlements and reverse payments could have under Article 81 EC. It seeks to identify the elements of the legal tests which could possibly be applied to assess the legality of such settlements and, in particular, those providing for a value transfer from the originator to the generic firm. This will be done as follows: Section 2 summarizes the main findings of the Final Report on settlement agreements; Section 3 makes an inventory of relatively old case law that dealt with comparable issues or those related to patent settlement agreements; and Section 4 makes an attempt to distill a legal test from the two previous sections for the assessment of patent settlement agreements between originator and generic firms under EC competition law.
Featured News
Starbucks Explored Chipotle Takeover in Potential Restaurant Megadeal
Oct 8, 2026 by
CPI
MMG Challenges EU Antitrust Case Against $500 Million Nickel Deal
Oct 8, 2026 by
CPI
Block, Parent of Cash App and Square, Faces FTC Probe Over Frozen Accounts
Oct 8, 2026 by
CPI
Michigan Sues Blue Cross Blue Shield Over Alleged Antitrust Violations
Oct 8, 2026 by
CPI
AkzoNobel, Axalta Near EU Approval for $25 Billion Merger
Oct 8, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – National Security
Sep 22, 2026 by
CPI
National Security in U.S. Antitrust Enforcement: Toward a More Disciplined Framework
Sep 22, 2026 by
Rod Rosenstein & Timothy Finley
The Department of War’s M&A Review Guidance: What Companies in the Defense Industry Need to Know
Sep 22, 2026 by
Eric Stocking & Paul Ney
National Security, Resilience and the Boundaries of Merger Control
Sep 22, 2026 by
Beatriz Marques
National Security and Competition: Building Resilient Telecommunications Networks
Sep 22, 2026 by
Roslyn Layton